View in EDS HTML Full Text PDF Full Text

Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.
Authors: Singareeka Raghavendra A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Damodaran S; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Barcenas CH; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fuqua SA; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Layman RM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Source: CA: a cancer journal for clinicians [CA Cancer J Clin] 2026 Jan-Feb; Vol. 76 (1), pp. e70055.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0370647 Publication Model: Print Cited Medium: Internet ISSN: 1542-4863 (Electronic) Linking ISSN: 00079235 NLM ISO Abbreviation: CA Cancer J Clin Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41524544
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singareeka+Raghavendra+A%22">Singareeka Raghavendra A</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Damodaran+S%22">Damodaran S</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Barcenas+CH%22">Barcenas CH</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Fuqua+SA%22">Fuqua SA</searchLink>; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Layman+RM%22">Layman RM</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370647%22">CA: a cancer journal for clinicians</searchLink> [CA Cancer J Clin] 2026 Jan-Feb; Vol. 76 (1), pp. e70055.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370647 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1542-4863 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200079235%22">00079235 </searchLink><i>NLM ISO Abbreviation: </i>CA Cancer J Clin <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41524544
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3322/caac.70055
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70055
    Titles:
      – TitleFull: Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singareeka Raghavendra A
      – PersonEntity:
          Name:
            NameFull: Damodaran S
      – PersonEntity:
          Name:
            NameFull: Barcenas CH
      – PersonEntity:
          Name:
            NameFull: Fuqua SA
      – PersonEntity:
          Name:
            NameFull: Layman RM
      – PersonEntity:
          Name:
            NameFull: Tripathy D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan-Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1542-4863
          Numbering:
            – Type: volume
              Value: 76
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: CA: a cancer journal for clinicians
              Type: main
ResultId 1